
Sign up to save your podcasts
Or


The use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD) is discussed in this podcast.
We hope you enjoy the #FGPodcast. Please follow @FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on Apple Podcasts: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229
By BMJ GroupThe use of anti-diabetic medications such as pioglitazone or GLP-1 receptor agonists in the management of metabolic dysfunction-associated steatotic liver disease (MASLD) is discussed in this podcast.
We hope you enjoy the #FGPodcast. Please follow @FrontGastro_BMJ. Listen to our regular podcasts and subscribe in Apple Podcasts and Spotify. If you enjoy our podcast, please rate us on your chosen platform, and leave us a review on the Frontline Gastroenterology Podcast page on Apple Podcasts: https://podcasts.apple.com/gb/podcast/fg-podcast/id942944229

317 Listeners

497 Listeners

35 Listeners

48 Listeners

68 Listeners

4 Listeners

7 Listeners

5 Listeners

3 Listeners

1 Listeners

3 Listeners

9 Listeners

40 Listeners

14 Listeners

1 Listeners

50 Listeners

6 Listeners

350 Listeners

16 Listeners

3 Listeners

22 Listeners

194 Listeners

92 Listeners

23 Listeners

368 Listeners

48 Listeners

2 Listeners

0 Listeners

851 Listeners

17 Listeners

0 Listeners

0 Listeners

0 Listeners